Candidemia in cancer patients: Impact of early removal of non-tunneled central venous catheters on outcome

Journal of Infection

Volumn 58, Issue 2, 2009, Pages 154-160

  Liu, C Y ^a,a,b,b   Huang, L J ^a,b   Wang, W S ^b   Chen, T L ^a,b   Yen, C C ^a,b   Yang, M H ^a,b   Hsiao, L T ^a,b   Chen, P M ^a,b   Chiou, T J ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cancer; Candidemia; Central venous catheter

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE; VORICONAZOLE;

ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; CANCER PATIENT; CANDIDA; CANDIDA ALBICANS; CANDIDEMIA; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FUNGUS ISOLATION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OUTCOMES RESEARCH; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; SURVIVAL TIME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; CANDIDA; CANDIDIASIS; CATHETERIZATION, CENTRAL VENOUS; FEMALE; FUNGEMIA; HUMANS; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 59749098320     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.12.008     Document Type: Article

References (37)

1. Edwards Jr. J.E. Invasive candida infections-evolution of a fungal pathogen. N Engl J Med 324 15 (1991) 1060-1062
2. Raad I., Hanna H., Boktour M., Girgawy E., Danawi H., Mardani M., et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 38 8 (2004) 1119-1127
3. Nucci M., Silveira M.I., Spector N., Silveira F., Velasco E., Akiti T., et al. Risk factors for death among cancer patients with fungemia. Clin Infect Dis 27 1 (1998) 107-111
4. Pappas P.G., Rex J.H., Sobel J.D., Filler S.G., Dismukes W.E., Walsh T.J., et al. Guidelines for treatment of candidiasis. Clin Infect Dis 38 2 (2004) 161-189
5. Walsh T.J., and Rex J.H. All catheter-related candidemia is not the same: assessment of the balance between the risks and benefits of removal of vascular catheters. Clin Infect Dis 34 5 (2002) 600-602
6. Nucci M., and Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin Infect Dis 34 5 (2002) 591-599
7. Stamos J.K., and Rowley A.H. Candidemia in a pediatric population. Clin Infect Dis 20 3 (1995) 571-575
8. Rex J.H., Bennett J.E., Sugar A.M., Pappas P.G., Serody J., Edwards J.E., et al. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis 21 4 (1995) 994-996
9. Nucci M., Colombo A.L., Silveira F., Richtmann R., Salomao R., Branchini M.L., et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 19 11 (1998) 846-850
10. Nguyen M.H., Peacock Jr. J.E., Tanner D.C., Morris A.J., Nguyen M.L., Snydman D.R., et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155 22 (1995) 2429-2435
11. Luzzati R., Amalfitano G., Lazzarini L., Soldani F., Bellino S., Solbiati M., et al. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 19 8 (2000) 602-607
12. Karlowicz M.G., Hashimoto L.N., Kelly Jr. R.E., and Buescher E.S. Should central venous catheters be removed as soon as candidemia is detected in neonates?. Pediatrics 106 5 (2000) E63
13. Hung C.C., Chen Y.C., Chang S.C., Luh K.T., and Hsieh W.C. Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc 95 1 (1996) 19-28
14. Eppes S.C., Troutman J.L., and Gutman L.T. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J 8 2 (1989) 99-104
15. Dato V.M., and Dajani A.S. Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J 9 5 (1990) 309-314
16. Almirante B., Rodriguez D., Park B.J., Cuenca-Estrella M., Planes A.M., Almela M., et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43 4 (2005) 1829-1835
17. Lecciones J.A., Lee J.W., Navarro E.E., Witebsky F.G., Marshall D., Steinberg S.M., et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis 14 4 (1992) 875-883
18. Girmenia C., Martino P., De Bernardis F., Gentile G., Boccanera M., Monaco M., et al. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis 23 3 (1996) 506-514
19. Anaissie E.J., Rex J.H., Uzun O., and Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 104 3 (1998) 238-245
20. Viscoli C., Girmenia C., Marinus A., Collette L., Martino P., Vandercam B., et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 28 5 (1999) 1071-1079
21. Pappas P.G., Rex J.H., Lee J., Hamill R.J., Larsen R.A., Powderly W., et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis 37 5 (2003) 634-643
22. Nolla-Salas J., Sitges-Serra A., Leon-Gil C., Martinez-Gonzalez J., Leon-Regidor M.A., Ibáñez-Lucía P., et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 23 1 (1997) 23-30
23. Alonso-Valle H., Acha O., Garcia-Palomo J.D., Farinas-Alvarez C., Fernandez-Mazarrasa C., and Farinas M.C. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 22 4 (2003) 254-257
24. Pasqualotto A.C., and Severo L.C. The importance of central venous catheter removal in patients with candidaemia: time to rethink our practice?. Clin Microbiol Infect 14 1 (2008) 2-4
25. Nucci M., and Anaissie E. Candidemia in patients with cancer: are persistent neutropenia and severity of illness score still relevant?. Clin Infect Dis 40 7 (2005) 1063-1064 [author reply 1064-7]
26. Rodriguez D., Park B.J., Almirante B., Cuenca-Estrella M., Planes A.M., Mensa J., et al. Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin Microbiol Infect 13 8 (2007) 788-793
27. Uzun O., and Anaissie E.J. Predictors of outcome in cancer patients with candidemia. Ann Oncol 11 12 (2000) 1517-1521
28. Safdar N., and Maki D.G. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 30 1 (2004) 62-67
29. Greene F.L. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg 87 7 (2002) 13-15
30. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 10 12 (1999) 1419-1432
31. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 6 (1982) 649-655
32. Charles P.E., Doise J.M., Quenot J.P., Aube H., Dalle F., Chavanet P., et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 29 12 (2003) 2162-2169
33. Tumbarello M., Posteraro B., Trecarichi E.M., Fiori B., Rossi M., Porta R., et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 45 6 (2007) 1843-1850
34. Kontoyiannis D.P., Reddy B.T., Hanna H., Bodey G.P., Tarrand J., and Raad I.I. Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity. Infect Control Hosp Epidemiol 23 9 (2002) 542-545
35. Quindos G., Salesa R., Carrillo-Muñoz A.J., Lipperheide V., Jaudenes L., San Millan R., et al. Multicenter evaluation of ATB fungus: a standardized micromethod for yeast susceptibility testing. Chemotherapy 40 4 (1994) 245-251
36. Kuhn D.M., Chandra J., Mukherjee P.K., and Ghannoum M.A. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70 2 (2002) 878-888
37. Ramage G., Vande Walle K., Wickes B.L., and Lopez-Ribot J.L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrobial Agents Chemother 45 9 (2001) 2475-2479